Horizon Therapeutics Public Ltd Co

FORSTA AP-FONDEN

Report date

9/30/2023

Quarter

2023 Q3

Filed

10/25/2023

Shares

42,400

Value ($000)

4,905

Weight

0.1%

2020 Q4 - 2023 Q3 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	10/25/2023	4,905	0.1%	42,400	9/30/2023
2023 Q2	8/3/2023	4,268	0.0%	41,500	6/30/2023
2023 Q1	4/21/2023	4,649	0.1%	42,600	3/31/2023
2022 Q4	2/2/2023	5,644	0.1%	49,600	12/31/2022
2022 Q3	10/17/2022	2,575	0.0%	41,600	9/30/2022
2022 Q2	8/11/2022	3,493	0.0%	43,800	6/30/2022
2022 Q1	5/9/2022	3,966	0.0%	37,700	3/31/2022
2021 Q4	2/11/2022	4,688	0.0%	43,500	12/31/2021
2021 Q3	11/10/2021	4,502	0.1%	41,100	9/30/2021
2021 Q2	8/12/2021	4,916	0.1%	52,500	6/30/2021
2021 Q1	5/11/2021	4,326	0.1%	47,000	3/31/2021
2020 Q4	2/9/2021	2,875	0.0%	39,300	12/31/2020